Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

María Lourdes Linares

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|August 22, 2020
Flow chemistry as a tool to access novel chemical space for drug discoveryEnol López, María Lourdes Linares, Jesús Alcázar
ACS Omega|September 13, 2021
Scaffold Hopping to Imidazo[1,2-<i>a</i>]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 ReceptorAna I de Lucas, Juan A Vega, Aránzazu García Molina, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1<i>H</i>-benzimidazol-2-ones as mGlu<sub>2</sub> Receptor PAMsAna Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptorGary Tresadern, Jose María Cid, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry|August 29, 2024
Discovery of 6,7-Dihydropyrazolo[1,5-<i>a</i>]pyrazin-4(5<i>H</i>)-one Derivatives as mGluR<sub>2</sub> Negative Allosteric Modulators with <i>In Vivo</i> Activity in a Rodent's Model of CognitionSergio A Alonso de Diego, María Lourdes Linares, Aránzazu García Molina, et al.
Journal of the American Chemical Society|July 25, 2024
Late-Stage C(<i>sp</i><sup>2</sup>)-C(<i>sp</i><sup>3</sup>) Diversification via Nickel Oxidative Addition ComplexesCarlota Odena, Tomás G Santiago, María Lourdes Linares, et al.
Journal of Medicinal Chemistry|February 23, 2012
Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptorAndrés A Trabanco, Gary Tresadern, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry|October 18, 2012
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptorJose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry|September 1, 2016
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry|July 18, 2014
Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptorJosé María Cid, Gary Tresadern, Guillaume Duvey, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|August 22, 2020
Flow chemistry as a tool to access novel chemical space for drug discoveryEnol López, María Lourdes Linares, Jesús Alcázar
ACS Omega|September 13, 2021
Scaffold Hopping to Imidazo[1,2-<i>a</i>]pyrazin-8-one Positive Allosteric Modulators of Metabotropic Glutamate 2 ReceptorAna I de Lucas, Juan A Vega, Aránzazu García Molina, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Spiro-oxindole Piperidines and 3-(Azetidin-3-yl)-1<i>H</i>-benzimidazol-2-ones as mGlu<sub>2</sub> Receptor PAMsAna Isabel de Lucas, Juan Antonio Vega, Encarnación Matesanz, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2009
Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptorGary Tresadern, Jose María Cid, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry|August 29, 2024
Discovery of 6,7-Dihydropyrazolo[1,5-<i>a</i>]pyrazin-4(5<i>H</i>)-one Derivatives as mGluR<sub>2</sub> Negative Allosteric Modulators with <i>In Vivo</i> Activity in a Rodent's Model of CognitionSergio A Alonso de Diego, María Lourdes Linares, Aránzazu García Molina, et al.
Journal of the American Chemical Society|July 25, 2024
Late-Stage C(<i>sp</i><sup>2</sup>)-C(<i>sp</i><sup>3</sup>) Diversification via Nickel Oxidative Addition ComplexesCarlota Odena, Tomás G Santiago, María Lourdes Linares, et al.
Journal of Medicinal Chemistry|February 23, 2012
Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptorAndrés A Trabanco, Gary Tresadern, Gregor J Macdonald, et al.
Journal of Medicinal Chemistry|October 18, 2012
Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptorJose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry|September 1, 2016
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)Jose María Cid, Gary Tresadern, Juan Antonio Vega, et al.
Journal of Medicinal Chemistry|July 18, 2014
Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptorJosé María Cid, Gary Tresadern, Guillaume Duvey, et al.
Pageof 2